Interleukin-17A (IL-17A): A silent amplifier of COVID-19

One of the hallmarks of COVID-19 is the cytokine storm that provokes primarily pneumonia followed by systemic inflammation. Emerging evidence has identified a potential link between elevated interleukin-17A (IL-17A) levels and disease severity and progression. Considering that per se, IL-17A can act...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biomed Pharmacother
Autores principales: Maione, Francesco, Casillo, Gian Marco, Raucci, Federica, Salvatore, Cristian, Ambrosini, Giovanna, Costa, Luisa, Scarpa, Raffaele, Caso, Francesco, Bucci, Mariarosaria
Formato: Artigo
Lenguaje:Inglês
Publicado: The Author(s). Published by Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318692/
https://ncbi.nlm.nih.gov/pubmed/34364043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111980
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares